If you live in Colorado and are researching compounded GLP-1 medications, this page is meant to save you some digging. It explains how access works in the state, what Colorado’s rules actually say about telehealth prescribing and compounded medications, what happened with the state’s much-discussed compounding bill this spring, what compounded semaglutide and tirzepatide cost, and how several providers serving Colorado compare on published cash prices. Everything here is drawn from public sources, with links, so you can check our work.
One disclosure up front: this site is operated by Gentle Health, a telehealth provider offering compounded GLP-1 treatment for weight management. Gentle Health appears in the comparison table below on the same terms as every other provider listed, and nothing on this page ranks one provider over another.
How compounded GLP-1 access works in Colorado
Colorado does not require an in-person clinic visit to be evaluated for a GLP-1 prescription. The state treats telehealth as the practice of medicine, full stop: a physician who evaluates, treats, or prescribes for a patient located in Colorado is practicing medicine in Colorado, needs a Colorado license, and is held to the same standard of care as if the visit happened in an exam room. Within that framework, a physician can evaluate you remotely, decide whether treatment is appropriate, and prescribe if it is.
Here is what that looks like in practice for a Gentle Health patient in Colorado:
- Complete a medical intake. You answer questions about your health history, current medications, and goals. This is the information a physician needs to decide whether a GLP-1 is appropriate for you.
- Physician review. Your intake is reviewed by James Simmons, MD, who is licensed to practice in Colorado through the Interstate Medical Licensure Compact (license CDR.0007266, state board record), of which Colorado is a member state. Dr. Simmons evaluates every Colorado patient individually; not everyone who applies is approved.
- Prescription and fulfillment. If Dr. Simmons determines treatment is appropriate, the prescription is sent to a licensed compounding pharmacy, and the medication ships to your home anywhere in Colorado, from Julesburg to Durango.
- Ongoing care. Dosing is adjusted over time based on how you respond, and you can reach Dr. Simmons with questions between check-ins.
The practical upshot: a patient in Craig or Lamar has the same access as a patient in Denver. That matters in a state where the Front Range holds most of the specialists and the Western Slope, the Eastern Plains, and the San Luis Valley hold most of the driving distance.
A note on the Compact, since it comes up: a license issued through the IMLC is not a lighter version of a Colorado license. It is a full, unrestricted license issued by the Colorado Medical Board, and a physician who holds one answers to that board like any other Colorado licensee. What the Compact changes is the paperwork timeline for qualified physicians already licensed in other member states.
Colorado rules worth knowing
Two threads matter here: how Colorado regulates telehealth prescribing, and what the state has been doing lately about compounded GLP-1s specifically. The second thread had an unusually eventful spring.
Telehealth prescribing. The Colorado Medical Board treats telehealth as the practice of medicine and has issued guidance on its appropriate use, and the Center for Connected Health Policy maintains a current summary of Colorado’s telehealth rules. A few points worth knowing:
- The practice of medicine occurs where the patient is located. If you are in Colorado, your prescriber needs a Colorado license, wherever that prescriber happens to sit.
- A provider-patient relationship can be established through telehealth, but it must actually be established. Prescribing based solely on an online questionnaire, without a real evaluation of your history and current condition, is not permitted.
- Treatment recommendations made through telehealth, including prescriptions, are held to the same standards of practice as in-person care. There is no separate, looser standard for online visits.
- Informed consent for the telehealth encounter should be obtained and documented.
GLP-1 medications are not controlled substances, so the stricter state and federal rules that govern telehealth prescribing of controlled substances do not apply here.
On the pharmacy side, Colorado requires any out-of-state pharmacy that ships prescription medications to Colorado patients to register with the State Board of Pharmacy as a nonresident prescription drug outlet, which keeps mail-order compounding pharmacies inside the Board’s reach.
The compounded GLP-1 bill that almost passed. Colorado spent much of 2026 debating Senate Bill 26-066, “Regulation of Compounded Weight-Loss Medication”, one of the first state-level attempts in the country to regulate compounded GLP-1s directly. The bill would have required anyone selling or distributing compounded GLP-1 medications in Colorado to confirm the medication was made from pharmaceutical-grade, FDA-registered-facility ingredients with a certificate of analysis, to label every active and inactive ingredient with quantities and country of origin, to carry a prominent not-FDA-approved warning, and to keep records open to Board of Pharmacy inspection, with fines of up to $1,000 per dose for violations and enforcement by the state attorney general under the Colorado Consumer Protection Act.
It got far: the Senate passed it 20-15 on April 17, 2026. Then the House Health & Human Services Committee voted on May 5, 2026 to postpone it indefinitely, which killed it for the session. So as of this writing, no Colorado-specific compounded GLP-1 statute is in force, and the general rules of the state’s Pharmacy Practice Act and federal law apply. But the bill’s near-passage tells you where regulatory attention is pointed, and versions of it may well return in a future session.
The federal backdrop. Under Section 503A of the Food, Drug and Cosmetic Act, pharmacies may compound medication for an individual patient under a valid prescription, but generally may not compound “essentially copies” of commercially available drugs. During the national semaglutide and tirzepatide shortages, those products were not considered commercially available, which opened the door to large-scale compounding. The FDA declared both shortages resolved, semaglutide in February 2025, and its enforcement grace periods for compounders ended in spring 2025. What remains lawful in 2026 is patient-specific compounding under a prescriber’s individualized judgment, not mass-produced copies. Federal scrutiny of this space has continued through 2026: on April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound these drugs from bulk substances. The public comment period closed June 29, 2026, and a final decision is pending. That proposal concerns 503B outsourcing facilities; patient-specific compounding under Section 503A is a separate pathway.
None of this is a reason to avoid asking questions. It is a reason to ask more of them: who is prescribing, which pharmacy is compounding, and whether both are licensed for Colorado.
Compounded semaglutide in Colorado
Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your body already makes, one that signals fullness, slows how quickly your stomach empties, and helps regulate blood sugar. The practical effect most patients describe is that food quiets down: smaller portions satisfy, and the constant background negotiation with appetite eases.
Compounded semaglutide is prepared by a licensed compounding pharmacy for an individual patient, based on a prescription. It is not FDA-approved, and that is a factual difference worth understanding rather than a footnote: compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before dispensing. Oversight comes instead from state boards of pharmacy and from the prescribing physician’s judgment about the individual patient. The ingredient-sourcing and labeling questions that Colorado’s SB26-066 tried to write into law are exactly the questions a careful patient should be asking any provider today.
Gentle Health offers compounded semaglutide to Colorado patients in two forms, at dose-tiered cash prices:
- Oral semaglutide: starting at $112 per month. Taken daily, no needles involved.
- Injectable semaglutide: starting at $135 per month. A once-weekly subcutaneous injection with a small needle.
Both prices are cash-pay and dose-tiered; the monthly price changes if the prescribed dose moves into a different tier. Treatment is subject to medical evaluation by Dr. Simmons, and continuing care is included rather than billed separately.
Compounded tirzepatide in Colorado
Tirzepatide works on two hormone receptors rather than one: GLP-1 and GIP. Like semaglutide, it is prescribed for weight management alongside changes to eating and activity; the dual mechanism is the main pharmacological distinction between the two medications. Which one is appropriate for a given patient, if either, is a clinical decision rather than a menu choice, and it depends on health history, other medications, and how a patient responds over time.
Compounded tirzepatide, like compounded semaglutide, is prepared for an individual patient by a licensed compounding pharmacy and is not FDA-approved.
Gentle Health offers compounded injectable tirzepatide to Colorado patients starting at $169 per month, cash-pay, priced according to the prescribed dose tier, once weekly. As with semaglutide, the evaluation, the prescription decision, and ongoing dose adjustments are handled by James Simmons, MD.
Provider options in Colorado: comparison table
Methodology: rows are ordered alphabetically; prices were taken only from each provider’s public web pages on 2026-07-27, and where a provider does not publish a price we say “See site” rather than guessing. Gentle Health operates this site and is listed on the same terms as everyone else. We do not rank providers.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves Colorado | Insurance | Source |
|---|---|---|---|---|---|---|
| AFC Urgent Care Denver | In-person clinics (Denver metro locations) with medical weight-management program | See site | See site | Yes (Denver-area clinics) | See site | afcurgentcare.com (verified 2026-07-27) |
| Eden | Telehealth; medication price plus separate membership ($39 first month, then $99/mo) | $99 + membership | $199 + membership | See site | Not required; HSA/FSA eligible | eden.health (verified 2026-07-27) |
| Gentle Health (operates this site) | Telehealth; care by James Simmons, MD; dose-tiered pricing, no separate membership fee | From $112 oral / from $135 injectable | From $169 | Yes | No insurance; cash-pay only | gentle.health (verified 2026-07-27) |
| Mochi Health | Telehealth; medication price plus $79/mo membership | $99 + membership | $199 + membership | Yes (serves all US states per its FAQ) | See site | joinmochi.com (verified 2026-07-27) |
| Noom Med | Telehealth; low-dose program bundling care and medication, billed $537 per 12 weeks after intro | From $179 (low-dose program) | See site | See site (Noom notes its programs are not available in all states) | Not required; FSA/HSA eligible | noom.com (verified 2026-07-27) |
| Remedy Meds | Telehealth; subscription plans, month-to-month | See site | See site | See site | Not required; HSA/FSA accepted | remedymeds.com (verified 2026-07-27) |
A few reading notes. Headline medication prices and total monthly cost are not the same thing: where a provider charges a separate membership fee, your real monthly outlay is the sum of the two lines. Intro prices are common in this market, so it is worth checking what month four costs, not just month one. In-person programs often price by dose tier, so ask what happens to the bill as your dose changes. And every provider on this list requires a medical evaluation; a price is only relevant if a licensed prescriber determines treatment is appropriate for you.
Frequently asked questions: compounded GLP-1 in Colorado
Is compounded semaglutide legal in Colorado? Compounding for an individual patient under a valid prescription is legal under federal law (Section 503A) and Colorado law when the pharmacy is properly licensed and the compounded product is not an essential copy of a commercially available drug. Colorado considered adding its own layer of state regulation in 2026 through SB26-066, but the bill died in a House committee in May, so no Colorado-specific compounded GLP-1 statute is currently in force.
Do I need an in-person doctor visit to get a GLP-1 prescription in Colorado? No. Colorado allows a provider-patient relationship to be established through telehealth, and prescriptions issued through telehealth are held to the same standard of care as in-person prescribing. What Colorado does not allow is prescribing based solely on an online questionnaire with no real evaluation; a licensed provider must actually assess your history and current condition. See the Center for Connected Health Policy’s Colorado summary for the current rules.
Who prescribes for Gentle Health patients in Colorado? James Simmons, MD, who is licensed to practice medicine in Colorado through the Interstate Medical Licensure Compact. A Compact license is a full Colorado license issued by the Colorado Medical Board. Every prescription decision at Gentle Health is made by Dr. Simmons based on an individual medical evaluation.
What was Colorado’s SB 66, and does it affect me? SB26-066 was a 2026 bill that would have imposed ingredient-sourcing, labeling, disclosure, and recordkeeping requirements on anyone selling compounded GLP-1 medications in Colorado, with attorney general enforcement. It passed the Senate 20-15 and was then postponed indefinitely by a House committee on May 5, 2026. It is not law. For patients, its practical legacy is a useful checklist: ask any provider where the medication is compounded, how ingredients are sourced, and what is on the label.
Does insurance cover compounded GLP-1s in Colorado? Generally, no. Insurance plans typically do not cover compounded medications. Most providers in this market, Gentle Health included, are cash-pay. Some accept HSA or FSA funds; check the individual provider’s site.
How does the medication get to me? After a prescription is issued, a licensed compounding pharmacy prepares your medication and ships it to your address in Colorado. Out-of-state pharmacies shipping into Colorado must be registered with the State Board of Pharmacy as nonresident prescription drug outlets. Shipments are packaged for temperature control where the formulation requires it.
Can I get compounded GLP-1 treatment anywhere in Colorado, or only along the Front Range? Anywhere in the state. Because the model is telehealth plus home delivery, a patient in Alamosa, Meeker, or Springfield has the same access as a patient in Denver or Colorado Springs. That is arguably where telehealth matters most: outside the Front Range corridor, obesity medicine specialists are scarce and the drives are long. Plan details and current dose tiers for the state are on our Colorado page, with local pages for Lakewood, Fort Collins and Denver. Wherever you start, the same physician reviews the intake and the published price holds.
Current Gentle Health dose tiers and pricing
Gentle Health pricing depends on the dose tier prescribed by your clinician. Current monthly prices are:
Oral compounded semaglutide
| Tier | Daily dose | Monthly price |
|---|---|---|
| Starting | 2-4 mg/day | $112/mo |
| Medium | >4-8 mg/day | $189/mo |
| High dose | >8-12 mg/day | $258/mo |
Injectable compounded semaglutide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 0.24-0.48 mg/wk | $135/mo |
| Medium | >0.48-1.2 mg/wk | $159/mo |
| High dose | >1.2-2.4 mg/wk | $199/mo |
Injectable compounded tirzepatide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 2.5-5 mg/wk | $169/mo |
| Medium | >5-10 mg/wk | $219/mo |
| High dose | >10-15 mg/wk | $269/mo |
Medication, the initial review by a licensed clinician, video visits and messaging, and overnight refrigerated shipping are included. There is no separate membership fee, and HSA and FSA cards are accepted. Your clinician determines the appropriate medication and dose; the monthly price changes if the prescribed dose moves into a different tier.
Gentle Health serves patients across a growing multistate footprint through clinicians licensed in each patient’s jurisdiction, including Colorado.
Reviewed by James Simmons, MD
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.